After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Verve Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $17.54 and fluctuated between $17.73 as its day high and $15.00 as its day low. The current market capitalization of Verve Therapeutics Inc is $1.38B. A total of 2.39 million shares were traded on the day, compared to an average of 1.17M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, VERV has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Dorval Allison sold 554 shares of VERV for 11.45 per share on Nov 29. After the transaction, the Chief Financial Officer now owns 4,060 company shares.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for VERV in the last 3 months, the mean price target is $45.89 with high estimates of $75.00 and low estimates of $22.00. In terms of 52-week highs and lows, VERV has a high of $21.42 and a low of $8.22.
As of this writing, VERV has an earnings estimate of -$0.82 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of -$0.7 per share and a lower estimate of -$0.93. The company reported an EPS of -$0.87 in the last quarter, which was 5.40% higher than expectations of -$0.92.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. VERV’s latest balance sheet shows that the firm has $360.44M in Cash & Short Term Investments as of fiscal 2021. There were $1.96M in debt and $22.02M in liabilities at the time. Its Book Value Per Share was $7.22, while its Total Shareholder’s Equity was $357.35M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VERV is Buy with a score of 4.18.
